STOCK INFORMATION

Genmab is a dual listed company with shares traded on the Copenhagen stock exchange in Denmark and on NASDAQ Global Select Market in the US.

ADR Program

ADR Program

Genmab’s American Depositary Receipt (ADR) Program

Genmab established a sponsored Level 3 ADR program with Deutsche Bank Trust Company Americas.  An ADS represents ownership of shares in a non-US corporation.  ADSs issued under Genmab's ADR Program are quoted and traded in US dollars on the Nasdaq Global Select Market in the United States. Ten Genmab ADSs correspond to one Genmab ordinary share. 

Click here to access Genmab's ADS details on Deutsche Bank's website.

ADR ticker symbol: GMAB
Structure: Level 3 ADS
Exchange: Nasdaq Global Select Market
Ratio: 10 ADRs : 1 ordinary share
DR ISIN : US3723032062
CUSIP: 372303 206

Contact details for ADS investors and brokers:
Deutsche Bank ADS broker services desks
New York: +1 212 250 9100
London: +44 207 547 6500

Contact details for registered ADS Holders:
Deutsche Bank Shareholder Services
AST
Operations Center
6201 15th Avenue
Brooklyn, NY 11219
USA

Email: DB@astfinancial.com 

Toll-free: +1 866 706 0509
Toll: +1 718 921 8137

ADR FAQs
More FAQs are coming soon.

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.